COVID-19 and cardiovascular disease.

Guijarro, Carlos

COVID-19 and cardiovascular disease. / COVID-19 y enfermedad cardiovascular.

Guijarro, Carlos.

Guijarro C; Unidad de Medicina Interna. Consulta de Riesgo Vascular, Hospital Universitario Fundación Alcorcón. Universidad Rey Juan Carlos, c/ Budapest 1 28922, Madrid. Electronic address: cguijarro@fhalcorcon.es.

Clin Investig Arterioscler ; 32(6): 263-266, 2020.

Article in English, Spanish | MEDLINE | ID: covidwho-942820

Subject(s)

COVID-19/complications; Cardiovascular Diseases/etiology; SARS-CoV-2; Angiotensin-Converting Enzyme 2/metabolism; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; COVID-19/epidemiology; Cardiovascular Diseases/prevention & control; Endothelium, Vascular/physiology; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Pandemics; Risk Factors; SARS-CoV-2/physiology; Spike Glycoprotein, Coronavirus/metabolism; Thrombosis/epidemiology; Thrombosis/etiology; Toll-Like Receptor 3/metabolism; Virus Internalization; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cardiovascular Diseases / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English / Spanish Journal: Clin Investig Arterioscler Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google